Posted on 8/8/17
Teva Pharmaceutical: An Opportunity Or A Falling Knife?
Teva Pharmaceutical Industries (TEVA) is the largest generic medicines pharmaceutical company in the world. It's estimated that one out of five prescriptions dispensed in the US . . .
Posted on 8/8/17
Teva Plunged More But Mylan Still The Better Pick
Article BriefSince late 2013, the share prices of the two leading generics names, Teva Pharmaceutical Industries (TEVA) and Mylan (MYL), have moved largely in tandem with . . .
Posted on 8/8/17
Teva Pharmaceuticals Had a Very Bad Day, in a Very Bad Year
In this Market Foolery podcast segment, host Chris Hill and Motley Fool One's Bill Mann consider how much worse Teva Pharmaceutical Industries (NYSE:TEVA) looks presently, after . . .
Posted on 8/7/17
MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria
MSD Animal Health, known as Merck Animal Health in the United States and Canada, today announced plans to purchase a new manufacturing facility in Krems an . . .
Posted on 8/7/17
Inovio: The Dilution Solution
IntroductionStartups of every variety need cash to operate. Biotech startups often find that they can use shares in their company as a means to acquire cash. . . .
Posted on 8/7/17
Celgene vs. Gilead Sciences: Who Reported Better Earnings?
Celgene Corp. (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) reported second-quarter earnings that were better than industry-watchers' forecasts, but these two giants' circumstances are very different. While Celgene . . .
Posted on 8/7/17
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) is a staple in the portfolios of conservative long-term investors and seniors alike.For decades, J&J, as the company is more . . .
Posted on 8/7/17
Teva Receives Big Blow On Generics Pricing
Recently, Teva Pharmaceutical (NYSE:TEVA) released its second-quarter earnings report. The report showed that the company missed on both its bottom-line and top-line of expectations. The root . . .
Posted on 8/7/17
Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day
What happenedShares of Teva Pharmaceutical Industries (NYSE:TEVA) are down 9.8% as 1:15 p.m. EDT after dropping by an even greater amount yesterday following disappointing second-quarter results . . .
Posted on 8/7/17
John Theurer Cancer Center and MedStar Georgetown University Hospital Announce 100th Blood Stem Cell Transplant
WASHINGTON & HACKENSACK, N.J.--(BUSINESS WIRE)--MedStar Georgetown University Hospital in Washington, D.C. in collaboration with John Theurer Cancer Center, part of Hackensack Meridian Health, Hackensack University Medical . . .
Posted on 8/4/17
Janney Healthcare Group Participates in Transactions for PLx Pharma
PLx Pharma Inc. (NASDAQ:PLXP), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg, announced that it has . . .
Posted on 8/4/17
Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter
Buying the Actavis Generics business from Allergan (NYSE:AGN) made the difference for Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) when it reported first-quarter results in May. That deal . . .
Posted on 8/4/17
Why AmerisourceBergen Corp. Fell Dramatically Today
What happenedAmerisourceBergen (NYSE:ABC) closed down 10.5% on Thursday after announcing disappointing fiscal third-quarter earnings and reducing its expectations for revenue for the entire fiscal 2017. Fellow . . .
Posted on 8/4/17
Cognizant Technology Rides the Digital Enterprise Wave
Across nearly every industry, businesses want to take advantage of the rise of innovation in information technology. Between cloud computing, data analytics, the Internet of Things, . . .
Posted on 8/4/17
Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone
What happenedIn response to reporting rough second-quarter results, shares of Teva Pharmaceutical Industries (NYSE:TEVA), a leading provider of generic drugs, dropped 24% as of 1:15 p.m. . . .
Posted on 8/4/17
Spark Therapeutics Prices $350M Offering
PHILADELPHIA, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. (NASDAQ:ONCE) announced today the pricing of an underwritten public offering of 4,605,264 shares of its common . . .
Posted on 8/4/17
Citius Pharmaceuticals Prices $6,800,000 Public Offering And Listing On The Nasdaq Capital Market
CITIUS PHARMACEUTICALS, INC. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the pricing of an underwritten . . .
Posted on 8/3/17
Akers Biosciences Announces Second Quarter Trading Update
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),, a developer of rapid health information technologies, announces that sales in the second quarter ended June 30, 2017 were . . .
Posted on 8/3/17
North Carolina Ranks among the Top 10 States Saving on Prescription Medications
Florida tops the list of states nationwide saving on their meds with FamilyWizeFamilyWize, the well-known prescription savings program that has helped over 10 million Americans save . . .
Posted on 8/3/17
Pfizer - Investors Remain Skeptical About Growth And The Pipeline
Pfizer (PFE) continues to post stagnant results, despite the fact that it spent vast sums on M&A in recent years. The company continues to promise the . . .
Posted on 8/3/17
Pfizer: Why The Stock May Get Interesting Again
BackgroundPfizer (PFE) delivered an in-line Q2, with consensus Street forward estimates for this year and next changing little. Rather than get into the details of a . . .
Posted on 8/3/17
A Large-Scale Acquisition Is Unlikely for Pfizer Until This Happens
Pharma titan Pfizer (NYSE:PFE) announced second-quarter earnings on Tuesday, but the drugmaker's performance was clearly a secondary issue for analysts and investors alike. Despite beating consensus . . .
Posted on 8/3/17
Spark Therapeutics Announces Proposed Public Offering of Common Stock
PHILADELPHIA, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. (NASDAQ:ONCE) announced today that it has commenced an underwritten public offering of $300,000,000 in shares of . . .
Posted on 8/3/17
Wedgewood Pharmacy Receives P.E.T. Award
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy, the largest animal-health compounding pharmacy in the U.S., received the inaugural P.E.T. Award, given at the PSI Business Symposium on July 30 . . .
Posted on 8/2/17
Pfizer (PFE) Q2 2017 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE)Q2 2017 Earnings CallAugust 01, 2017 10:00 am ETExecutivesCharles E. Triano - Pfizer Inc.Ian C. Read - Pfizer Inc.Frank A. D'Amelio - Pfizer Inc.John . . .

